2 assets in Helicobacter Pylori Infectious Disease

Therapeutic assets addressing Helicobacter Pylori Infectious Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Bifidobacterium Tetravaccae Helicobacter Pylori Infectious Disease	Nanjing First Hospital, Nanjing Medical University	P4	BB (65)
Umbellatine Helicobacter Pylori Infectious Disease	Nanjing First Hospital, Nanjing Medical University	P4	BB (65)